Zolmitriptan 5 MG ODT UD 3S
Ended Awarded Last action
- Contract number
- SPE2DR26FR0JX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $49,198
Award facts
- Contract value 100% obligated
- $49,198.49 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on January 7, 2026, for the supply of Zolmitriptan 5 mg orally disintegrating tablets in unit dose packages of three, with a contract ceiling value of $49,198.49 and an ultimate completion date of January 8, 2026. This non-set-aside, competitively awarded delivery order utilizes firm fixed-price pricing and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen Drug Corp's parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2031. This prime IDC vehicle enables comprehensive global pharmaceutical support to military healthcare programs and serves as the contracting mechanism for this and similar delivery orders across multiple therapeutic domains.
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement, particularly for military and veteran healthcare systems. The company demonstrates extensive capability in fulfilling government pharmaceutical supply requirements through its established track record of delivering brand-name and generic medications, specialty pharmaceuticals, and medical supplies to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. This delivery order for Zolmitriptan, a migraine treatment medication, exemplifies the company's role in supporting the medical supply chain for federal military and healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FR0JX?
SPE2DR26FR0JX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26FR0JX worth?
The government has obligated $49,198 on SPE2DR26FR0JX.
Is contract SPE2DR26FR0JX an order under another contract?
Yes. SPE2DR26FR0JX is a delivery order under SPE2DR25D3006, an indefinite delivery contract.
Was contract SPE2DR26FR0JX competed?
The extent of competition for SPE2DR26FR0JX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award